Powered by Oncomine™ from Thermo Fisher Scientific
Next-Gen Sequencing Lung Panel Based on Technologies of Biocept and Thermo Fisher Scientific
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support resources.
- Exclusive, targeted and actionable; approximately 70% of biomarkers investigated are based on NCCN Guidelines and/or FDA approved therapies
- Cost effective NGS-based solution
- Turn-around-time (7-10 days upon receipt of specimen in most cases)
- Specimen requirements: 8 mLs of peripheral blood in CEE-SURE™ or EDTA Tube
- Sensitivity: 96-99% (MAF ≥0.1%)
- Raw data file available for further research
Current Gene List
All genes in blue font are referenced in NCCN Guidelines and/or are associated with FDA-approved therapy.
Sample Reports
Order Now
Contact us to learn how Biocept can support your research and testing.
Target Selector Kits are for research use only. Not for use in diagnostic procedures.